Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125267622 | 12526762 | 2 | F | 20160623 | 20160705 | 20160705 | EXP | US-ACTAVIS-2016-14517 | ACTAVIS | WEISBERG LS1. LACTIC ACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CLIN J AM SOC NEPHROL. 2015;10:1476-83. | 49.00 | YR | M | Y | 0.00000 | 20160705 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125267622 | 12526762 | 1 | SS | Metformin (Unknown) | METFORMIN HYDROCHLORIDE | 1 | Unknown | 2500 MG, DAILY; DIVIDED IN 3 DOSES | UNCONFIRMED | 0 | 2500 | MG | UNK | QD | |||||
| 125267622 | 12526762 | 2 | SS | Metformin (Unknown) | METFORMIN HYDROCHLORIDE | 1 | Unknown | 1000 MG, DAILY | UNCONFIRMED | 0 | 1000 | MG | UNK | QD | |||||
| 125267622 | 12526762 | 3 | SS | Furosemide (Watson Laboratories) | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 160 MG, UNKNOWN | U | UNCONFIRMED | 0 | 160 | MG | UNK | |||||
| 125267622 | 12526762 | 4 | SS | Furosemide (Watson Laboratories) | FUROSEMIDE | 1 | Unknown | 40 MG, DAILY | U | UNCONFIRMED | 0 | 40 | MG | UNK | QD | ||||
| 125267622 | 12526762 | 5 | SS | Furosemide (Watson Laboratories) | FUROSEMIDE | 1 | Unknown | 80 MG, BID | U | UNCONFIRMED | 0 | 80 | MG | UNK | BID | ||||
| 125267622 | 12526762 | 6 | PS | Spironolactone (AELLC) | SPIRONOLACTONE | 1 | Unknown | UNK | U | UNCONFIRMED | 40353 | UNK | |||||||
| 125267622 | 12526762 | 7 | SS | Dobutamine Hydrochloride (Watson Laboratories) | DOBUTAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK, MAXIMUM DOSE | UNCONFIRMED | 0 | UNK | ||||||||
| 125267622 | 12526762 | 8 | SS | PHENYLEPHRINE | PHENYLEPHRINEPHENYLEPHRINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK, MAXIMUM DOSE | 0 | ||||||||||
| 125267622 | 12526762 | 9 | SS | EPINEPHRINE. | EPINEPHRINE | 1 | Intravenous (not otherwise specified) | UNK, MAXIMUM DOSE | 0 | ||||||||||
| 125267622 | 12526762 | 10 | SS | NOREPINEPHRINE | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | Intravenous (not otherwise specified) | UNK, MAXIMUM DOSE | 0 | ||||||||||
| 125267622 | 12526762 | 11 | SS | VASOPRESSIN. | VASOPRESSIN | 1 | 0 | ||||||||||||
| 125267622 | 12526762 | 12 | C | INSULIN | INSULIN NOS | 1 | Unknown | UNK | U | 0 | |||||||||
| 125267622 | 12526762 | 13 | C | DIGOXIN. | DIGOXIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125267622 | 12526762 | 14 | C | WARFARIN | WARFARIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125267622 | 12526762 | 15 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125267622 | 12526762 | 16 | C | METOLAZONE. | METOLAZONE | 1 | Unknown | 2.5 MG, DAILY | U | 0 | 2.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125267622 | 12526762 | 1 | Type 2 diabetes mellitus |
| 125267622 | 12526762 | 3 | Product used for unknown indication |
| 125267622 | 12526762 | 6 | Product used for unknown indication |
| 125267622 | 12526762 | 7 | Cardiac failure congestive |
| 125267622 | 12526762 | 8 | Cardiac failure congestive |
| 125267622 | 12526762 | 9 | Cardiac failure congestive |
| 125267622 | 12526762 | 10 | Cardiac failure congestive |
| 125267622 | 12526762 | 11 | Cardiac failure congestive |
| 125267622 | 12526762 | 12 | Product used for unknown indication |
| 125267622 | 12526762 | 13 | Product used for unknown indication |
| 125267622 | 12526762 | 14 | Product used for unknown indication |
| 125267622 | 12526762 | 15 | Product used for unknown indication |
| 125267622 | 12526762 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125267622 | 12526762 | HO |
| 125267622 | 12526762 | OT |
| 125267622 | 12526762 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125267622 | 12526762 | Blood creatinine increased | |
| 125267622 | 12526762 | Lactic acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |